Lyra Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 229.38 K | $1.50 M | -10.10% | 17.01% |
| SABBY MANAGEMENT, LLC | 11/14/2025 | 127.62 K | $832.87 K | 1.51% | 9.46% |
| VANGUARD GROUP INC | 11/07/2025 | 28.75 K | $189.49 K | -1.45% | 2.13% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 21.16 K | $139.45 K | 0.00% | 1.57% |
| CITADEL ADVISORS LLC | 11/14/2025 | 19.48 K | $128.40 K | 100.00% | 1.44% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 10.99 K | $72.41 K | 0.00% | 0.81% |
| UBS GROUP AG | 11/13/2025 | 4.00 K | $26.11 K | 199,950.00% | 0.30% |
| BLACKROCK, INC. | 11/12/2025 | 1.69 K | $11.03 K | 0.00% | 0.13% |
| ROYAL BANK OF CANADA | 11/14/2025 | 1.33 K | $9.00 K | 20.24% | 0.10% |
| MORGAN STANLEY | 11/14/2025 | 1.28 K | $8.34 K | -40.99% | 0.09% |
| CITIGROUP INC | 11/10/2025 | 705 | $4.65 K | -11.32% | 0.05% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 534 | $3.49 K | -63.99% | 0.04% |
| FMR LLC | 11/13/2025 | 406 | $2.68 K | -76.77% | 0.03% |
| SIGNATURE RESOURCES CAPITAL MANAGEMENT, LLC | 10/16/2025 | 400 | $2.61 K | 0.00% | 0.03% |
| EVERSOURCE WEALTH ADVISORS, LLC | 11/10/2025 | 345 | $2.25 K | -3.63% | 0.03% |
| JONES FINANCIAL COMPANIES LLLP | 11/04/2025 | 210 | $1.36 K | 2,000.00% | 0.02% |
| FORTITUDE FAMILY OFFICE, LLC | 10/17/2025 | 96 | $627 | 100.00% | 0.01% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 80 | $522 | -5.88% | 0.01% |
| JPMORGAN CHASE & CO | 11/26/2025 | 27 | $178 | -85.94% | 0.00% |
| COMERICA BANK | 11/14/2025 | 23 | $150 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 22 | $143 | 100.00% | 0.00% |
| BRYN MAWR TRUST CO | 11/20/2025 | 20 | $131 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 18 | $117 | -99.94% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 16 | $104 | -36.00% | 0.00% |
| IFP ADVISORS, INC | 12/02/2025 | 2 | $13 | -66.67% | 0.00% |
| PRINCIPAL SECURITIES, INC. | 11/12/2025 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| VALLEY NATIONAL ADVISERS INC | 10/17/2025 | 0 | $0 | -100.00% | 0.00% |
| STATE OF WISCONSIN INVESTMENT BOARD | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 10/23/2025 | 0 | $0 | -100.00% | 0.00% |
| CWM, LLC | 10/15/2025 | 0 | $0 | -100.00% | 0.00% |
| IFP ADVISORS, INC | 12/02/2025 | 0 | $0 | -100.00% | 0.00% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Lyra Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 37 institutional investors and hedge funds held shares of Lyra Therapeutics, Inc.. The most heavily invested institutionals were:
PERCEPTIVE ADVISORS LLC: 229,382
SABBY MANAGEMENT, LLC: 127,624
VANGUARD GROUP INC: 28,754
Ikarian Capital, LLC: 21,161
CITADEL ADVISORS LLC: 19,484
GEODE CAPITAL MANAGEMENT, LLC: 10,986
33.26% of Lyra Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 4.39 M shares in the last 24 months. This purchase volume represents approximately $30.61 M in transactions.